JOHNSON & JOHNSON |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,640 ARS | -1.22% |
|
+3.64% | +34.59% |
| 07-03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
| 07-03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
c308e54e29794.7DtB8v9j6YQfY3a6SqgwcjNKBeFFe2SdV-eB0fQe9u4.oF0Wh5sH0csmMiKCKNECR1IzYJZ0PhXNb7PllrJ0zoyiVnOnsRfcy3tUOw~39b476d65d258a0b49682f84e241681b
